Immune Biomarkers in Prostate Cancer Patients Treated With Brachytherapy
Recruiting
Observational Study
Prostate Cancer (Diagnosis)
Prostate Cancer Patients Who Have Brachytherapy Seed Implant
Prostate Cancer Patients Treated by Radiotherapy
Prostate Cancer Recurrent
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Male
- Study type
- Observational
- Participants needed
- 200 (estimated)
- Sponsor
- University of Erlangen-Nürnberg Medical School · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Analysis of peripheral immune cells before, during, and after brachytherapy treatment. Corresponding analysis of tissue samples collected during brachytherapy treatment.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria Arm 1:
* Primary treatment with I-125 seeds or HDR-BT
* No previous treatment for prostate cancer
* Age ≥ 18 years
Inclusion Criteria Arm 2:
* HDR- or PDR-BT
* No radiation therapy within three months before salvage treatment
* Complete documentation available on previous treat…
Contacts
Anna-Jasmina Donaubauer, Dr. rer. nat.
CONTACT